Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
CRISPR Therapeutics AG
Swot
CRISPR Therapeutics AG SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
CRISPR Therapeutics AG has 7 Strengths, 11 Weaknesses, 2 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(7)
Weakness
(11)
Opportunity
(2)
Threats
(2)
Others
(2)
MACD Crossover Above Signal Line
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
MACD crossed above signal line previous end of day
Companies with Low Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Stock with Low PE (PE < = 10)
Momentum Trap (DVM)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Risky Value (DVM)
Low durability companies
Top Losers
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Weak performer : Stock lost more than 20% in 1 month
RSI indicating price weakness
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter
Companies with Upcoming Results
Institutions increasing their shareholding
Mutual Funds Decreased Shareholding in Past Month
MFs decreased their shareholding last quarter
Promoters increasing shareholding QoQ
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
